可信遗传因素与GLP1-RA及减重手术后体重下降的关联
该研究分析来自6个国家9个多祖先生物样本库研究的10960名个体,评估已知遗传因素对体重下降的影响。GLP1-RA使用者在6至12个月平均体重变化为-3.93%或-6.00%(取决于结局定义),减重手术患者在6至48个月为-21.17%。未发现GLP1-RA减重与BMI或2型糖尿病多基因评分及GLP1R错义变异显著相关;较高BMI多基因评分与减重手术后体重下降较少呈 modest 关联(每标准差+0.7%,P=1.24×10-4),但敏感性分析中效应减弱。
要点
- GLP1-RA使用者6至12个月平均体重变化为-3.93%或-6.00%,减重手术患者6至48个月为-21.17%。
- 未发现GLP1-RA减重与BMI或2型糖尿病多基因评分及GLP1R错义变异显著相关。
- 较高BMI多基因评分与减重手术后体重下降较少呈 modest 关联(每标准差+0.7%,P=1.24×10-4),敏感性分析中效应减弱。
核心结论
- 已知遗传因素对GLP1-RA在体重变化方面的有效性影响有限,并证实各祖先群体中治疗有效性。
研究设计与样本
- 分析来自6个国家9个多祖先生物样本库研究的10960名个体,评估已知遗传因素对体重下降的影响。
主要发现
- GLP1-RA使用者在6至12个月平均体重变化为-3.93%或-6.00%(取决于结局定义),存在 modest 的祖先群体差异。
- 减重手术患者在6至48个月体重变化为-21.17%。
- 未发现GLP1-RA诱导的体重下降与BMI或2型糖尿病多基因评分显著相关,也未发现与GLP1R错义变异显著相关。
- 较高BMI多基因评分与减重手术后体重下降较少呈 modest 关联(每标准差+0.7%,P=1.24×10-4),但敏感性分析中效应减弱。
局限性
- 较高BMI多基因评分与减重手术后体重下降较少的关联在敏感性分析中效应减弱。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Obesity is a major public health challenge. Glucagon-like peptide-1 receptor agonists (GLP1-RA) and bariatric surgery (BS) are effective weight loss interventions; however, the genetic factors influencing treatment response remain largely unexplored. Moreover, most previous studies have focused on race and ethnicity rather than genetic ancestry. Here we analyzed 10,960 individuals from 9 multiancestry biobank studies across 6 countries to assess the impact of known genetic factors on weight loss. Between 6 and 12 months, GLP1-RA users had an average weight change of -3.93% or -6.00%, depending on the outcome definition, with modest ancestry-based differences. BS patients experienced -21.17% weight change between 6 and 48 months. We found no significant associations between GLP1-RA-induced weight loss and polygenic scores for body mass index or type 2 diabetes, nor with missense variants in GLP1R. A higher body mass index polygenic score was modestly linked to lower weight loss after BS (+0.7% per s.d., P = 1.24 × 10-4), but the effect attenuated in sensitivity analyses. Our findings suggest known genetic factors have limited impact on GLP1-RA effectiveness with respect to weight change and confirm treatment efficacy across ancestry groups.
引用
- German J, Cordioli M, Tozzo V, et al. Association between plausible genetic factors and weight loss from GLP1-RA and bariatric surgery. Nat Med. 2025. PMID: 40251273. doi:10.1038/s41591-025-03645-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。